Cost-effectiveness of neoadjuvant (NeoAdj) versus adjuvant (Adj) therapies for resectable pancreatic cancer (PC).
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: R. T. Shroff, M. M. Javle, S. Krishnan, S. B. Cantor, J. E. Lee, J. B. Fleming, G. R. Varadhachary, J. L. Abbruzzese, R. A. Wolff, L. S. Elting
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2493430425